JP7774276B2 - ペプチドを含む組成物及びその用途 - Google Patents

ペプチドを含む組成物及びその用途

Info

Publication number
JP7774276B2
JP7774276B2 JP2022546284A JP2022546284A JP7774276B2 JP 7774276 B2 JP7774276 B2 JP 7774276B2 JP 2022546284 A JP2022546284 A JP 2022546284A JP 2022546284 A JP2022546284 A JP 2022546284A JP 7774276 B2 JP7774276 B2 JP 7774276B2
Authority
JP
Japan
Prior art keywords
cys
gly
pro
peptide
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022546284A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022050176A5 (https=
JPWO2022050176A1 (https=
Inventor
健太郎 小嶋
寛 田中
陽一郎 新開
隆規 小出
慎一郎 市瀬
博 能勢
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KOLA-GEN PHARMA INC.
Original Assignee
KOLA-GEN PHARMA INC.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KOLA-GEN PHARMA INC. filed Critical KOLA-GEN PHARMA INC.
Publication of JPWO2022050176A1 publication Critical patent/JPWO2022050176A1/ja
Publication of JPWO2022050176A5 publication Critical patent/JPWO2022050176A5/ja
Application granted granted Critical
Publication of JP7774276B2 publication Critical patent/JP7774276B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2022546284A 2020-09-02 2021-08-27 ペプチドを含む組成物及びその用途 Active JP7774276B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020147265 2020-09-02
JP2020147265 2020-09-02
PCT/JP2021/031436 WO2022050176A1 (ja) 2020-09-02 2021-08-27 ペプチドを含む組成物及びその用途

Publications (3)

Publication Number Publication Date
JPWO2022050176A1 JPWO2022050176A1 (https=) 2022-03-10
JPWO2022050176A5 JPWO2022050176A5 (https=) 2024-07-09
JP7774276B2 true JP7774276B2 (ja) 2025-11-21

Family

ID=80491732

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022546284A Active JP7774276B2 (ja) 2020-09-02 2021-08-27 ペプチドを含む組成物及びその用途

Country Status (5)

Country Link
US (1) US20230295269A1 (https=)
EP (1) EP4209505A4 (https=)
JP (1) JP7774276B2 (https=)
CN (1) CN115698054A (https=)
WO (1) WO2022050176A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023127888A1 (en) * 2021-12-29 2023-07-06 Kola-Gen Pharma Inc. Novel peptides

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005263784A (ja) 2004-02-16 2005-09-29 Techno Network Shikoku Co Ltd コラーゲン様構造を有するポリペプチド
JP2017014126A (ja) 2015-06-29 2017-01-19 学校法人早稲田大学 抗微生物活性を有するコラーゲン様ペプチド及びその組成物
JP2018104461A (ja) 2011-12-14 2018-07-05 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー コラーゲン結合タンパク質による治療剤の送達

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016208673A1 (ja) 2015-06-25 2016-12-29 学校法人早稲田大学 コラーゲン様構造を有する重合ペプチド及びゲル

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005263784A (ja) 2004-02-16 2005-09-29 Techno Network Shikoku Co Ltd コラーゲン様構造を有するポリペプチド
JP2018104461A (ja) 2011-12-14 2018-07-05 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー コラーゲン結合タンパク質による治療剤の送達
JP2017014126A (ja) 2015-06-29 2017-01-19 学校法人早稲田大学 抗微生物活性を有するコラーゲン様ペプチド及びその組成物

Also Published As

Publication number Publication date
JPWO2022050176A1 (https=) 2022-03-10
EP4209505A4 (en) 2024-10-23
EP4209505A1 (en) 2023-07-12
US20230295269A1 (en) 2023-09-21
WO2022050176A1 (ja) 2022-03-10
CN115698054A (zh) 2023-02-03

Similar Documents

Publication Publication Date Title
US8183343B2 (en) Methods for treating a skin wound
JP2010155842A5 (https=)
US20250134946A1 (en) Self-assembling amphiphilic peptide hydrogels for treatment of nerve injury
JP7774276B2 (ja) ペプチドを含む組成物及びその用途
CN108602852B (zh) 组胺素及其使用方法
JP7787610B2 (ja) ポリエチレングリコール化コラーゲン様タンパク質の製造方法及びその使用
US9023795B2 (en) Angiogenesis-inhibiting peptide and application thereof
JP4253743B2 (ja) 新規ペプチドおよびその医薬用途
JPWO2005102375A1 (ja) Ｐａｃａｐおよびその誘導体を含有する角膜神経突起形成促進剤
US11998589B2 (en) PEGylated peptide amphiphile nanofibers and methods of use
CN102336812A (zh) 一种具有抑制血管生成活性的多肽
AU2017206626A1 (en) Pharmaceutical formulations and their use for the treatment of retinitis pigmentosa
CN101503458B (zh) 预防和治疗血管新生的小分子多肽及其应用
JPH0680694A (ja) 創傷治癒に活性のあるポリペプチド・ポリマーイオン複合体
US8933031B2 (en) Polypeptide inhibiting angiogenesis and application thereof
JP2016108323A (ja) 新規な機能性ペプチド
CA2738757A1 (en) Pharmaceutical compositions and methods of use for the prevention and treatment of hypoxic injury
CN104004057A (zh) 一类新的抑制新生血管的小肽及其应用
US20020160937A1 (en) Human vitreous and pharmaceutical compositions
CA2255477A1 (en) Human vitreous and pharmaceutical compositions

Legal Events

Date Code Title Description
AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20230517

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230525

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240626

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240626

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250604

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250723

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20251029

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20251102

R150 Certificate of patent or registration of utility model

Ref document number: 7774276

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150